Langerhan's Cell Sarcoma: Two Case Reports
Open Access
- 1 March 2016
- journal article
- Published by SAGE Publications in Rare Tumors
- Vol. 8 (1) , 17-19
Abstract
Langerhan's cell sarcoma (LCS) is a rare neoplasm with a poor prognosis. To our knowledge, only sixty-six cases have been published. We discuss two patients who presented very differently with LCS, as well as a recently published review of all sixty-six cases. Our first case had a complicated history of metastatic, high-grade myxofibrosarcomas and presented with a single skin lesion of LCS which was treated with resection to a positive margin and adjuvant radiotherapy. The LCS recurred locoregionally and was again resected. The patient is alive two years after initial diagnosis. The second case presented with bone marrow and splenic involvement, leukocytosis, and thrombocytopenia. This patient had an excellent response to etoposide, prednisone, oncovorin, cyclophosphamide, and adriamycin, with normalization of the complete blood count, negative bone marrow biopsy at follow up, and splenectomy without viable neoplasm. This patient is alive without signs of disease at 16 months after initial diagnosis.Keywords
This publication has 8 references indexed in Scilit:
- Langerhans cell sarcoma: A systematic reviewCancer Treatment Reviews, 2015
- Cutaneous Langerhans cell sarcoma relapsing systemically: Complete remission with the EPIG regimenAnnals of Hematology, 2014
- Primary Cutaneous Langerhans Cell SarcomaThe American Journal of Dermatopathology, 2013
- Langerhans cell sarcoma of the cervical lymph node: A case report and literature reviewAuris Nasus Larynx, 2010
- Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 casesHistopathology, 2002
- Langerin, a Novel C-Type Lectin Specific to Langerhans Cells, Is an Endocytic Receptor that Induces the Formation of Birbeck GranulesImmunity, 2000
- The monoclonal antibody DCGM4 recognizes Langerin, a protein specific of Langerhans cells, and is rapidly internalized from the cell surfaceEuropean Journal of Immunology, 1999
- Malignant histiocytosis X report of a rapidly fatal case in an elderly manCancer, 1984